Bharat Biotech co-founder Dr. Krishna Ella awarded by Johns Hopkins

Dr Krishna Ella. Pic/Bharat Biotech website

Dr. Krishna Ella, Co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health.

The award was presented to Dr. Ella during Bloomberg School's Convocation Ceremony on May 22 in Baltimore, Maryland, for his exceptional leadership, enduring vision and contribution to improving public health.

"John Hopkins Bloomberg School of Public Health acknowledges Dr. Ella's pioneering work, remarkable influence, and determination to develop an indigenous, innovative, and safe vaccines focused on global public health," stated a media statement by the company.

Sagar Kavach: Cops patrol at beaches

6 months agoWEBSTORY

On receiving the Dean's Medal from Johns Hopkins Bloomberg School of Public Health Dr. Krishna Ella said, "I acknowledge this medal as a global recognition of India's scientific excellence, and dedicate this medal to Bharat, which has shown remarkable success by advancing science and R&D, to our exemplary team of scientists, and the results of our strong commitment to public."

Under Dr. Ella's guidance, Bharat Biotech during the COVID-19 pandemic, developed COVAXIN, India's first Indigenous COVID-19 vaccine in a record time, conducting the largest-ever human clinical trials and peer-reviewed by world-leading medical journals.

"COVAXIN has been instrumental in the country's vision of self-reliance, in the fight against the virus, demonstrating significant efficacy and safety. The vaccine has been distributed globally, reinforcing Dr. Ella's commitment to advancing healthcare accessibility and innovation worldwide. He now serves as the President of the Indian Vaccine Manufacturers' Association (IVMA)," the statement stated.

Who is Dr Ella

Dr. Ella is a first-generation entrepreneur, who established Bharat Biotech in the year 1996 is widely acknowledged for not only leading his company into paediatric and adult vaccine development, but also establishing other enterprises focused on human health, animal health (Biovet India), food processing (Ella Foods), and contract research services.